Internet Of Medical Things Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Internet Of Medical Things Market Trends and Insights

Cost-reduction Pressure on Global Healthcare Systems

Healthcare providers face steep cost escalation, with United States supply-chain disruptions pushing expenses up by 15% in 2025. Connected devices cut unplanned downtime through predictive maintenance and real-time asset tracking, as illustrated by RWJBarnabas Health’s USD 9 million savings after deploying a location system that eliminated device losses^{[1]“Real Time Location Systems Deliver Return on Investment,” Stanley Healthcare, stanleyhealthcare.com}. Value-based reimbursement amplifies adoption because hospitals must document outcome improvements alongside cost controls. Capital budgets consequently treat the Internet of Medical Things market as essential infrastructure, prompting multiyear procurement commitments. Insurers further link reimbursement to documented savings, reinforcing a cycle that channels operating funds to connected platforms.

Proliferation of Connected Wearables and Implantables

Breakthroughs in wireless power and miniaturized sensor arrays now permit battery-free devices that transmit only relevant data, conserving bandwidth and energy. Brown University demonstrated salt-sized sensors capable of monitoring intracranial pressure and glucose simultaneously, enabling continuous care without recurrent surgery. Consumer demand for preventive health data broadens deployment beyond clinical settings, ensuring the Internet of Medical Things market finds growth in wellness as well as disease management. Device makers embed edge AI that filters noise before transmission, reducing cloud-processing costs. Regulatory pathways are smoothing as real-world performance data accumulates, shortening approval cycles for next-generation implants.

Shift to Outcomes-based and Remote Patient-Monitoring Models

Outcomes-linked contracts reward providers for measurable improvements rather than service volume, accelerating connected-device uptake^{[2]Marie Johnson, “Hospital-at-Home Model Saves Millions,” American Hospital Association, aha.org}. Guthrie Clinic’s virtual hub saved USD 7 million in labor and cut nurse turnover to 13% through remote monitoring. COVID-19 validated hospital-at-home models that now receive routine reimbursement in mature markets. Asia Pacific outpaces other regions in digital-health tool adoption, with AI decision support integrated across many public systems. The Internet of Medical Things market benefits as continuous data streams support personalized care pathways while easing capacity constraints.

Roll-out of Private 5G and Edge Networks in Hospitals

Hospitals view private 5G as foundational for latency-sensitive applications such as remote surgery. Sweden’s USD 35 million VGR-5G program links 500 medical facilities, replacing legacy DECT voice systems. China’s First Affiliated Hospital of Soochow University connected more than 3,000 devices over a 5G network, cutting deployment time by 90%. Edge compute nodes process imaging and AI monitoring onsite, lowering bandwidth needs and enhancing resilience during connectivity interruptions. These networks' future-proof capacity for exploding data volumes as the Internet of Medical Things market scales. 

Shortage of In-house IoT Skills in Provider Organisations

Thirty percent of healthcare enterprises cite data-security expertise shortages as an adoption hurdle. Smaller hospitals struggle to recruit cyber-literate engineers, widening the gap between resource-rich systems and rural facilities. Managed services bridge some needs but introduce vendor-lock risks and subscription overhead. Talent deficits are pronounced in Southeast Asia despite high investment intent. Without robust in-house teams, deployment timelines extend, slowing Internet of Medical Things market penetration.

Escalating Ransomware Premiums Diverting IoMT Budgets

Healthcare ransomware incidents now average one breach per week, with per-incident costs reaching USD 10.93 million. Insurers require multi-factor authentication and network segmentation before underwriting, shifting funds from device procurement to security controls. The sector’s 61% ransom payment rate emboldens attackers, forcing providers to prioritize cyber defenses over expanded connectivity. Consequently, organizations face a chicken-and-egg dilemma: they need visibility tools to qualify for insurance, yet require insurance to approve device investments, tempering short-term Internet of Medical Things market growth.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Device Type: Implantables Drive Innovation Surge

Implantable devices represent the fastest-growing segment, projected to expand at 19.04% CAGR through 2031, while wearables maintained leadership with 26.62% share of the Internet of Medical Things market size in 2025. Wireless power transfer and sub-millimeter sensors eliminate battery replacements and support continuous multi-parameter measurement. Stationary in-hospital systems remain connectivity hubs for network orchestration, ensuring data integrity across thousands of endpoints. 

The University of California’s ultrasound-powered fluorescence sensor shows how deep-tissue imaging can guide cancer therapy without external leads. Wearables absorb these advances, combining sensor fusion with edge analytics to issue timely alerts. Emerging smart contact lenses and biodegradable probes add niche opportunities that diversify the Internet of Medical Things market. Regulatory approvals favor implants that demonstrate longitudinal safety and outcome benefits, encouraging sustained R&D spending.

By Product Type: Cardiac Devices Accelerate Growth

Vital-sign monitoring products held a 32.08% share in 2025, demonstrating their role as baseline tools across care settings. Implantable cardiac devices are slated to grow at a 17.62% CAGR, supported by closed-loop neuromodulation that optimizes therapy based on real-time neural feedback. Respiratory monitors gain relevance due to rising COPD prevalence, while anaesthesia machines integrate connected sensors to enhance intraoperative safety. 

Predictive maintenance algorithms applied to imaging systems and ventilators reduce downtime and extend asset life. Smart pill dispensers and connected rehabilitation gear broaden engagement beyond acute care, adding recurring revenue streams for vendors. Together, these dynamics elevate the Internet of Medical Things market and enhance cross-device ecosystem value.

By End User: Home-care Settings Transform Delivery

Hospitals retained 40.56% of the Internet of Medical Things market size in 2025, yet home-care settings are projected to grow at an 18.25% CAGR as virtual wards become mainstream. Continuous monitoring at home reduces readmissions and frees hospital beds for higher acuity cases. Clinics and nursing homes adopt connected workflows to optimize staffing and coordinate chronic-disease management. 

Guthrie Clinic’s virtual hub illustrates cost savings and staff retention benefits, marking a reference model for similar deployments. Progress in plug-and-play wireless sensors lowers installation barriers, enabling smaller providers to offer clinical-grade remote monitoring. These trends expand the Internet of Medical Things market into community care and pave the way for preventive service packages.

By Connectivity Technology: Cellular IoT Gains Momentum

Wi-Fi accounted for 44.28% of revenue in 2025, but cellular IoT and LPWAN solutions are forecast to climb at a 19.83% CAGR through 2031 as providers extend monitoring beyond facility walls. Private 5G within hospitals reserves dedicated bandwidth for mission-critical applications, while LTE-M and NB-IoT support low-power devices across broad geographies. 

Bluetooth continues to link wearables to smartphones, and Zigbee maintains relevance for sensor-dense environments. Emerging Li-Fi and satellite links serve remote or shielded locations, creating multi-path architectures that raise reliability. Edge processing at the radio gateway trims backhaul requirements, boosting scalability for the Internet of Medical Things market.

Geography Analysis

North America commanded a 38.22% share in 2025, propelled by mature health-IT infrastructure and regulatory pathways that encourage interoperability. Public-private alliances fast-track private-5G pilots and AI-enabled diagnostics. Canada and Mexico add momentum through government-funded telehealth initiatives, while rising cyber-insurance premiums and semiconductor shortages temper near-term device rollouts. Legacy system integration remains a capital-intensive obstacle, yet strong reimbursement models keep the Internet of Medical Things market advancing. 

Asia Pacific is the fastest-growing region at a 20.71% CAGR. China’s 2024 medical-informatization spending surpassed CNY 800 billion, underscoring state support. Japan and South Korea leverage advanced manufacturing to deliver next-generation sensors, and India’s national EHR rollout aids standardization. Skilled-personnel shortages persist, but cross-border training and cloud-based managed services lessen the gap. Regional collaboration spreads best practices, ensuring broad participation in the expanding Internet of Medical Things market. 

Europe records steady gains supported by Medical Device Regulation compliance that clarifies connected-device requirements. Germany, the United Kingdom, and France lead adoption through funded modernization programs, while Italy and Spain tap EU stimulus to upgrade infrastructure. Strict data-privacy laws elevate implementation costs yet build patient trust. Switzerland’s Kantonsspital Baden installed more than 7,000 sensors with Siemens, proving the scalability of smart-hospital visions. Harmonized policies let smaller economies piggyback on regional frameworks, sustaining Internet of Medical Things market momentum across the continent. 

Regulatory Landscape

Regulation for Internet of Medical Things (IoMT) products continues to be enforced through existing medical device frameworks rather than a standalone IoMT statute, which raises the role of cybersecurity and software lifecycle evidence in traditional submissions. In the United States, Section 524B of the FD&C Act (21 U.S.C. 360n-2) hardens premarket expectations for cyber devices by formalizing cybersecurity documentation, including SBOM and related lifecycle controls, as part of submissions routed through pathways such as 510(k), De Novo, and PMA.

For compliance, the FDA Quality Management System Regulation (QMSR) is a key anchor, effective February 2, 2026, and it is followed by the FDA updated cybersecurity guidance on February 3, 2026. Together, these steps align quality-system practice with cybersecurity-by-design. In Europe, connected-device compliance is shaped by the combination of sector rules (EU MDR/IVDR) and horizontal cybersecurity requirements under the EU Cyber Resilience Act (2024). In parallel, the European Commission proposal (COM(2025) 1023, December 2025) to amend MDR/IVDR signals an effort to reduce administrative burden while keeping core safety and performance obligations in place for connected technologies.

Value Chain Analysis

The IoMT value chain starts with component and subsystem suppliers (sensors, low-power compute, connectivity modules) and moves through device OEMs and software developers that embed security controls and data models into firmware, mobile apps, and gateways. Connectivity and platform layers (Wi-Fi, cellular IoT/LPWAN, private 5G, edge nodes, and cloud) then transport and process device data, which is integrated into provider workflows through interoperability interfaces to EHR and clinical systems. After deployment, cybersecurity monitoring and lifecycle support complete the loop.

Regulatory- and standards-driven work increasingly sits inside the chain rather than as an after-the-fact check. That shift encourages suppliers to provide evidence artifacts, such as SBOM inputs and secure development practices, that feed into OEM premarket and postmarket obligations. Interoperability and security standards also shape handoffs between ecosystem participants, including IEEE 11073 for device data exchange and service-oriented device connectivity approaches such as SDC. FDA recognition of AAMI CR515:2025 (added to the FDA recognized consensus standards database in March 2026) reinforces cybersecurity expectations for AI/ML-enabled medical devices, while integration remains a persistent friction point when heterogeneous device fleets and privacy and security requirements must scale from pilots to enterprise deployments across hospitals and home-care settings.

Market Opportunities and Future Outlook

A near-term opportunity is emerging at the point where cybersecurity compliance meets operational deployment. Providers and manufacturers are operationalizing the FDA QMSR (effective February 2, 2026) and the updated FDA cybersecurity guidance (February 3, 2026) with documentation-driven controls such as SBOM management, threat modeling, and secure update pipelines. This creates whitespace for software, services, and managed-security offerings designed for medical device fleets, particularly where cyber-insurance and audit readiness depend on continuous asset discovery and segmentation rather than one-time device onboarding.

Interoperability-led platform expansion is another opening with visible ecosystem signals. GE HealthCare joining OR.NET e.V. to support SDC indicates that multi-vendor device integration is being treated as core infrastructure. Philips selection of AWS as its preferred cloud provider, alongside its stated scale of over 1.3 million IoT devices connected to the cloud, reinforces demand for scalable data pipelines and device management across modalities and care sites. Standards alignment around HL7 FHIR for data exchange and EN ISO/IEEE 11073-10700:2025 for SDC also supports vendors that can translate standards into deployable, clinical-grade connectors and validation toolchains across hospitals, clinics, and home-care settings.